Literature DB >> 11473168

Corneal virulence of LasA protease--deficient Pseudomonas aeruginosa PAO1.

C D White1, L G Alionte, B M Cannon, A R Caballero, R J O'Callaghan, J A Hobden.   

Abstract

PURPOSE: Pseudomonas aeruginosa PAO1 deficient in LasA protease was reported to be ocularly avirulent. However, the avirulence of this mutant could not attributed to the loss of LasA protease. The purpose of this study was to define the mechanism for such a mutant's inability to cause corneal disease.
METHODS: A LasA protease--deficient mutant of P. aeruginosa PAO1 was constructed by allelic exchange. Virulence of this mutant in mouse and rabbit models of keratitis was assessed by scoring for ocular disease and quantitating viable bacteria from infected corneas. Adherence to scarified mouse corneal tissue was determined with an organ culture assay.
RESULTS: In the mouse eye, the LasA protease--deficient mutant was not virulent, despite being as adherent as its parent strain. Virulence of the mutant was also significantly reduced in the rabbit eye. Complementation with lasA did not restore virulence in either model of infection. Neither the mutant nor the mutant complemented with lasA grew well in ocular tissue. An analysis of the mutant showed that it was auxotrophic for leucine.
CONCLUSION: These data show that the mutant's avirulence in the eye is caused by poor growth in the ocular environment and not the loss of a functional lasA gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11473168     DOI: 10.1097/00003226-200108000-00017

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

1.  Staphylolysin is an effective therapeutic agent for Staphylococcus aureus experimental keratitis.

Authors:  Irina S Barequet; Nirit Bourla; Yuval N Pessach; Mary Safrin; Dalit Yankovich; Dennis E Ohman; Mordechai Rosner; Efrat Kessler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-24       Impact factor: 3.117

2.  Pseudomonas aeruginosa LasA protease in treatment of experimental staphylococcal keratitis.

Authors:  Irina S Barequet; Guy J Ben Simon; Mary Safrin; Dennis E Ohman; Efrat Kessler
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

3.  Properties of PASP: a Pseudomonas protease capable of mediating corneal erosions.

Authors:  Aihua Tang; Mary E Marquart; Jonathan D Fratkin; Clare C McCormick; Armando R Caballero; Hattie P Gatlin; Richard J O'Callaghan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-28       Impact factor: 4.799

4.  Pseudomonas aeruginosa exoproducts determine antibiotic efficacy against Staphylococcus aureus.

Authors:  Lauren Radlinski; Sarah E Rowe; Laurel B Kartchner; Robert Maile; Bruce A Cairns; Nicholas P Vitko; Cindy J Gode; Anne M Lachiewicz; Matthew C Wolfgang; Brian P Conlon
Journal:  PLoS Biol       Date:  2017-11-27       Impact factor: 8.029

Review 5.  Pseudomonas aeruginosa Keratitis: Protease IV and PASP as Corneal Virulence Mediators.

Authors:  Richard O'Callaghan; Armando Caballero; Aihua Tang; Michael Bierdeman
Journal:  Microorganisms       Date:  2019-08-22

6.  Infectious keratitis: secreted bacterial proteins that mediate corneal damage.

Authors:  Mary E Marquart; Richard J O'Callaghan
Journal:  J Ophthalmol       Date:  2013-01-08       Impact factor: 1.909

Review 7.  An Organ System-Based Synopsis of Pseudomonas aeruginosa Virulence.

Authors:  Charles D Morin; Eric Déziel; Jeff Gauthier; Roger C Levesque; Gee W Lau
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.